In connection with SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021 (updated as on April 13, 2022) and in connection with BSE circular LIST/COMP/05/2019-20 dated April 11, 2019, BSE Circular No. LIST/COMP/59/2019-20 dated March 3, 2020 and BSE Notice No. 20220427-2 dated April 27, 2022 (‘Circulars’), Fermenta Biotech has informed that the company is not a ‘Large Corporate’ (as defined in the Circulars) as per the financial statements as on March 31, 2025. The company has attached the relevant declarations in Annexure A and Annexure B2.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1865.95 |
| Dr. Reddys Labs. | 1339.35 |
| Cipla | 1456.95 |
| Zydus Lifesciences | 1108.85 |
| Lupin | 2396.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: